Start Date
June 30, 2003
Study Completion Date
September 30, 2006
irofulven
Sydney Cancer Centre at Royal Prince Alfred Hospital, Sydney
Cancer Institute at National University Hospital, Singapore
Johns Hopkins - Singapore, Singapore
National Cancer Centre - Singapore, Singapore
Prince of Wales Hospital, Shatin, New Territories
Yonsei Cancer Center at Yonsei University Medical Center, Seoul
Lead Sponsor
National Cancer Institute (NCI)
NIH
Cancer Therapeutics Research Group
OTHER